175 related articles for article (PubMed ID: 37996923)
21. Aggregate Effects of Intraocular Pressure and Cup-to-Disc Ratio Genetic Variants on Glaucoma in a Multiethnic Asian Population.
Tham YC; Liao J; Vithana EN; Khor CC; Teo YY; Tai ES; Wong TY; Aung T; Cheng CY;
Ophthalmology; 2015 Jun; 122(6):1149-57. PubMed ID: 25745874
[TBL] [Abstract][Full Text] [Related]
22. Genetic Variants Associated With the Onset and Progression of Primary Open-Angle Glaucoma.
Mabuchi F; Mabuchi N; Sakurada Y; Yoneyama S; Kashiwagi K; Iijima H; Yamagata Z; Takamoto M; Aihara M; Iwata T; Hashimoto K; Sato K; Shiga Y; Nishiguchi KM; Nakazawa T; Akiyama M; Kawase K; Ozaki M; Araie M;
Am J Ophthalmol; 2020 Jul; 215():135-140. PubMed ID: 32217119
[TBL] [Abstract][Full Text] [Related]
23. Biomarkers and special features of oxidative stress in the anterior segment of the eye linked to lens cataract and the trabecular meshwork injury in primary open-angle glaucoma: challenges of dual combination therapy with N-acetylcarnosine lubricant eye drops and oral formulation of nonhydrolyzed carnosine.
Babizhayev MA
Fundam Clin Pharmacol; 2012 Feb; 26(1):86-117. PubMed ID: 21883446
[TBL] [Abstract][Full Text] [Related]
24. Schlemm's Canal and Trabecular Meshwork in Eyes with Primary Open Angle Glaucoma: A Comparative Study Using High-Frequency Ultrasound Biomicroscopy.
Yan X; Li M; Chen Z; Zhu Y; Song Y; Zhang H
PLoS One; 2016; 11(1):e0145824. PubMed ID: 26726880
[TBL] [Abstract][Full Text] [Related]
25. [The effect of systemic antihypertensive drugs on the risk of primary open-angle glaucoma].
Plotnikov DY; Agliullina ST
Vestn Oftalmol; 2023; 139(3):23-29. PubMed ID: 37379106
[TBL] [Abstract][Full Text] [Related]
26. Habitual Coffee Consumption Increases Risk of Primary Open-Angle Glaucoma: A Mendelian Randomization Study.
Li X; Cheng S; Cheng J; Wang M; Zhong Y; Yu AY
Ophthalmology; 2022 Sep; 129(9):1014-1021. PubMed ID: 35537532
[TBL] [Abstract][Full Text] [Related]
27. Comparison of self-measured diurnal intraocular pressure profiles using rebound tonometry between primary angle closure glaucoma and primary open angle glaucoma patients.
Tan S; Baig N; Hansapinyo L; Jhanji V; Wei S; Tham CC
PLoS One; 2017; 12(3):e0173905. PubMed ID: 28333942
[TBL] [Abstract][Full Text] [Related]
28. Glaucoma risk alleles at CDKN2B-AS1 are associated with lower intraocular pressure, normal-tension glaucoma, and advanced glaucoma.
Burdon KP; Crawford A; Casson RJ; Hewitt AW; Landers J; Danoy P; Mackey DA; Mitchell P; Healey PR; Craig JE
Ophthalmology; 2012 Aug; 119(8):1539-45. PubMed ID: 22521085
[TBL] [Abstract][Full Text] [Related]
29. Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity.
Souma T; Tompson SW; Thomson BR; Siggs OM; Kizhatil K; Yamaguchi S; Feng L; Limviphuvadh V; Whisenhunt KN; Maurer-Stroh S; Yanovitch TL; Kalaydjieva L; Azmanov DN; Finzi S; Mauri L; Javadiyan S; Souzeau E; Zhou T; Hewitt AW; Kloss B; Burdon KP; Mackey DA; Allen KF; Ruddle JB; Lim SH; Rozen S; Tran-Viet KN; Liu X; John S; Wiggs JL; Pasutto F; Craig JE; Jin J; Quaggin SE; Young TL
J Clin Invest; 2016 Jul; 126(7):2575-87. PubMed ID: 27270174
[TBL] [Abstract][Full Text] [Related]
30. Integrating genetic regulation and single-cell expression with GWAS prioritizes causal genes and cell types for glaucoma.
Hamel AR; Yan W; Rouhana JM; Monovarfeshani A; Jiang X; Mehta PA; Advani J; Luo Y; Liang Q; Rajasundaram S; Shrivastava A; Duchinski K; Mantena S; Wang J; van Zyl T; Pasquale LR; Swaroop A; Gharahkhani P; Khawaja AP; MacGregor S; ; Chen R; Vitart V; Sanes JR; Wiggs JL; Segrè AV
Nat Commun; 2024 Jan; 15(1):396. PubMed ID: 38195602
[TBL] [Abstract][Full Text] [Related]
31. An Intraocular Pressure Polygenic Risk Score Stratifies Multiple Primary Open-Angle Glaucoma Parameters Including Treatment Intensity.
Qassim A; Souzeau E; Siggs OM; Hassall MM; Han X; Griffiths HL; Frost NA; Vallabh NA; Kirwan JF; Menon G; Cree AJ; Galanopoulos A; Agar A; Healey PR; Graham SL; Landers J; Casson RJ; Gharahkhani P; Willoughby CE; Hewitt AW; Lotery AJ; MacGregor S; Craig JE
Ophthalmology; 2020 Jul; 127(7):901-907. PubMed ID: 32081492
[TBL] [Abstract][Full Text] [Related]
32. Two-year outcomes of minimally invasive XEN Gel Stent implantation in primary open-angle and pseudoexfoliation glaucoma.
Rauchegger T; Angermann R; Willeit P; Schmid E; Teuchner B
Acta Ophthalmol; 2021 Jun; 99(4):369-375. PubMed ID: 32996702
[TBL] [Abstract][Full Text] [Related]
33. Effect of a Schlemm's Canal Microstent on Early Postoperative Intraocular Pressure after Cataract Surgery: An Analysis of the HORIZON Randomized Controlled Trial.
Zebardast N; Zheng C; Jampel HD
Ophthalmology; 2020 Oct; 127(10):1303-1310. PubMed ID: 32143828
[TBL] [Abstract][Full Text] [Related]
34. Circulating fatty acids and risk of primary open-angle glaucoma: A mendelian randomization study.
Bao J; Yang Z; Zheng S; Li J; Shentu X
Gene; 2022 Feb; 811():146078. PubMed ID: 34838945
[TBL] [Abstract][Full Text] [Related]
35. Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2.
Asrani S; Bacharach J; Holland E; McKee H; Sheng H; Lewis RA; Kopczynski CC; Heah T
Adv Ther; 2020 Apr; 37(4):1620-1631. PubMed ID: 32166538
[TBL] [Abstract][Full Text] [Related]
36. Determination of the Trans-Lamina Cribrosa Pressure Difference in a Community-Based Population and its Association with Open-Angle Glaucoma.
Tailor PD; Aul BJ; Sit AJ; Fautsch MP; Chen JJ
Ophthalmol Glaucoma; 2024; 7(2):168-176. PubMed ID: 37783273
[TBL] [Abstract][Full Text] [Related]
37. Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension.
Fingeret M; Gaddie IB; Bloomenstein M
Clin Exp Optom; 2019 Nov; 102(6):541-550. PubMed ID: 30614563
[TBL] [Abstract][Full Text] [Related]
38. Cannabis use and the risk of primary open-angle glaucoma: a Mendelian randomization study.
Katsimpris A; Baumeister SE; Baurecht H; Tatham AJ; Nolde M
Sci Rep; 2023 Nov; 13(1):19605. PubMed ID: 37949880
[TBL] [Abstract][Full Text] [Related]
39. Simplifying "target" intraocular pressure for different stages of primary open-angle glaucoma and primary angle-closure glaucoma.
Sihota R; Angmo D; Ramaswamy D; Dada T
Indian J Ophthalmol; 2018 Apr; 66(4):495-505. PubMed ID: 29582808
[TBL] [Abstract][Full Text] [Related]
40. Targeting the vascular-specific phosphatase PTPRB protects against retinal ganglion cell loss in a pre-clinical model of glaucoma.
Thomson BR; Carota IA; Souma T; Soman S; Vestweber D; Quaggin SE
Elife; 2019 Oct; 8():. PubMed ID: 31621585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
